Pitchdeck - 42. Deutscher Krankenhaustag€¦ · Pitchdeck Contact: alexander.krawinkel@fimo.io or...

Pitchdeck

Contact: alexander.krawinkel@fimo.io or visit www.fimo.io

FIMOis a data driven solution

to improve the quality of lifefor people suffering from fatigue

2

3

AFFECTED

1.1M(in GERMANY)

CHARAKTERISTICS

Extreme exhaustionTiredness

Cognitive disorders

DISORDERS

CancerMultiple SclerosisVirus infections

3

EXPLANATION OF A PATIENT

Source: German Multiple Sclerosisself-aid facebook group:„In 2019 everyone understands the following explanation. Fatigue is like charging your smartphone in the evening and in the morning the battery is still at 40%. Then you write 2 Whatsapp messages and the battery is in the red area. My body behaves the same way with fatigue.”

4

Physical Activity

Cognitive Activity

Noise

Temperature

Light

Stress

FATIGUE HAS MANY INFLUENCING FACTORS

5

VITAL PARAMETERS ENVIRONMENT

Temperature

Noise

Air pressure

Light

Weather

Passive Data measurement Active Data measurement

Symbol Digit Modalities Test WEIMuS Test

Pulse

HRV

Sleep

Physical activity

Stress

6

PROTOTYPE SOLUTION

Measurements ofrelevant data within

everyday life throughan app and a device

Big data analysis & machine learning

algorithms

7

SOLUTION - APPROACH

b

e

n

e

f

i

t

Startup phase

early stage mid stage late stage

DashboardPassive data collectionCharts and data export

All of the early stage:+ significance tests+ individual warnings

All of the mid stage:+ possible warningsbased on cross-sectional data

8

SOLUTION – CLIENT INTERACTION

Better understanding andpredictability of symptoms

Higher trust fromdoctors and family

Improved therapies Earlier diagnosis

VISION

9

SOLUTION – BENEFITS

~ 1 MPatients

~ 50 MPatients

> 5 Bn €R&D for new drugs

> 20 Bn €for therapies

and drugs

10

MARKET SIZE

Multiple Sclerosis 216‘ (2.500‘)

Cancer 429‘ (17.000‘)

CFS/ME 240‘ (17.000‘)

Parkinson 200‘ (6.100‘)

Stroke tbd tbd tbd

…

„healthy people“: air traffic controllers,

truck drivers, …tbd

Customer Group

Size in thousands(worldwide)

Relevance Access

1

2

311

TARGET USER GROUPS

Health insurance providers

benefit from decreasing costs, for example because fewer hospital stays are necessary and better treatments

are possible

B2B2C

Pharmaceutical companies

can measure and prove the efficacy of drugs & therapies

B2B

BUSINESS MODELL

12

Diseases

Fitness

SensoringCognitive focus

Symptom tracking

13

COMPETITION

All relevant datais measured

Medical contextis provided

Data analytics&

machine learning

Clear focuson fatigue

14

USP

15

DISEASES

Fatigue

Migraine

Narcolepsy

MOBILITY

Pilots / Air trafficcontrollers

Truck or Uber drivers

OTHER

Fitness: High performance sports

Security: Industrial workers

VISION

AlexanderKrawinkel

CEO

TEAM

DominikStiegeler

CTO

BenedictHöger

Head of IT

Jana Mäcken

Biostatistics

KiraHülsdünker

Health

MauriceKlaffehn

IT

M. Sc. Geography& Economics

B. Sc. Computer Science

B. Sc. ElectronicalEngineering

B. Sc. Computer Science

Ph.D. SocialPsychology

Medical Student

16

17

Prof. Dr. Andreas Mayr

Head of WG StatisticalMethods in Epidemiology

Prof. Dr. med.Michael Linnebank

Medical Director, Neurologyclinic Hagen-Ambrock

Prof. Dr. med.Stephanie Stock

Head of Institute for Health Economics and

Clinical Epidemiology

Prof. Dr. med.Andrew Chan

Clinical DirectorUniversitätsspital Bern

MENTORS & PARTNERS

1

2

3

4

2019• Clinical Trial• Exist scholarship

2020• Validation study• Seed funding

2021

2022• Series A• Market entry

• Medical device certification• Ready2Market product€ $

18

TIMELINE

19

Seed funding in 2020: $ 500k – 1M

Experts from pharmaceutical groups and health insurance providers

WE ARE LOOKING FOR…

Contact: alexander.krawinkel@fimo.io or visit www.fimo.io